Skip to main content

Table 4 Characteristics of PCV participants

From: Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy

 

Case

Control

 

Total PCV

P vs. control

Polypoidal CNV

P vs. control

P vs. typical PCV

Typical PCV

P vs. control

Subjects, n

282

 

84

  

198

 

274

Male/female

195/87

<0.0001*

63/21

<0.0001*

0.205

132/66

<0.0001*

110/164

Age(±SD)

70.0(±8.7)

<0.0001*

68.8(±8.9)

<0.0001*

0.130

70.5(±8.7)

<0.0001*

72.9(±7.4)

Hypertension

39%

0.390

38%

0.45

0.792

40%

0.509

43%

Diabetes

9%

<0.0001*

10%

0.032*

0.649

8%

<0.0001*

20%

Smoking

33%

<0.0001*

37%

<0.0001*

0.406

31%

0.001*

18%

Number of polyps

-

 

4.17

 

<0.0001*

1.95

 

-

GLD, mm

-

 

3.78

 

<0.0001*

2.78

 

-

  1. p-values reflect comparisons between each of the case groups and the control group, calculated using Fisher’s exact test *p < 0.05.
  2. PCV; polypoidal choroidal vasculopathy CNV; choroidal neovascularization GLD; greatest linear dimension SD; standard deviation.
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us